Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial
Smits PC, Chang CC, Chevalier B, West NEJ, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen JGP, Morice MC, Onuma Y, Van Geuns RJM (2020)
Publication Type: Journal article
Publication year: 2020
Journal
Book Volume: 16
Pages Range: 645-+
Journal Issue: 8
Abstract
Aims: The aim of this study was to investigate clinical outcomes of patients at high risk of restenosis after implantation of a bioresorbable vascular scaffold (BVS).
Authors with CRIS profile
Involved external institutions
Segeberger Kliniken
Germany (DE)
CERC Cardiovascular European Research Center
France (FR)
Jagiellonian University / Uniwersytet Jagielloński (UJ)
Poland (PL)
Università degli Studi di Napoli Federico II
Italy (IT)
Universidad Complutense de Madrid (UCM)
Spain (ES)
Erasmus University Medical Center (MC)
Netherlands (NL)
Johannes Gutenberg-Universität Mainz (JGU)
Germany (DE)
Onze-Lieve-Vrouwziekenhuis (OLV Ziekenhuis, OLVZ)
Belgium (BE)
Maasstad Ziekenhuis
Netherlands (NL)
Hôpital privé Jacques Cartier
France (FR)
University of Padua / Universita degli Studi di Padova
Italy (IT)
Royal Papworth Hospital NHS Foundation Trust
United Kingdom (GB)
Miedziowe Centrum Zdrowia
Poland (PL)
University of Amsterdam
Netherlands (NL)
Univerzita Karlova v Praze / Charles University in Prague
Czech Republic (CZ)
Germany (DE)
CERC Cardiovascular European Research Center
France (FR)
Jagiellonian University / Uniwersytet Jagielloński (UJ)
Poland (PL)
Università degli Studi di Napoli Federico II
Italy (IT)
Universidad Complutense de Madrid (UCM)
Spain (ES)
Erasmus University Medical Center (MC)
Netherlands (NL)
Johannes Gutenberg-Universität Mainz (JGU)
Germany (DE)
Onze-Lieve-Vrouwziekenhuis (OLV Ziekenhuis, OLVZ)
Belgium (BE)
Maasstad Ziekenhuis
Netherlands (NL)
Hôpital privé Jacques Cartier
France (FR)
University of Padua / Universita degli Studi di Padova
Italy (IT)
Royal Papworth Hospital NHS Foundation Trust
United Kingdom (GB)
Miedziowe Centrum Zdrowia
Poland (PL)
University of Amsterdam
Netherlands (NL)
Univerzita Karlova v Praze / Charles University in Prague
Czech Republic (CZ)
How to cite
APA:
Smits, P.C., Chang, C.C., Chevalier, B., West, N.E.J., Gori, T., Barbato, E.,... Van Geuns, R.-J.M. (2020). Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial. EuroIntervention, 16(8), 645-+. https://dx.doi.org/10.4244/EIJ-D-19-01079
MLA:
Smits, Pieter C., et al. "Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial." EuroIntervention 16.8 (2020): 645-+.
BibTeX: Download